Objectives-To describe 6 h urinary lead excretion (6 h PbU) after 1 g intravenous ethylene diamine tetraacetic acid (EDTA) in organolead manufacturing workers with mixed exposure to organic and inorganic lead; to determine the predictors of lead excretion (PbU); and to determine the extent to which internal lead stores and ongoing external exposure govern blood concentrations of lead (PbB).
Methods-A case series of 21 active workers were studied. Personal industrial hygiene data, grouped by 29 exposure zones, in combination with personal interviews about work location and times were used to derive several measures of recent and cumulative exposure to organic and inorganic lead. The average exposure intensities assigned to the 29 zones ranged from 4 to 119 4uglm3 (0-02-0.57 4Umollm3 as lead) for organic lead and from 1 to 56 4ug/m3 (0-004-0-27 4umol/m') for inorganic lead.
Results-After controlling for age, 6 h PbU was significantly and positively correlated with summary measures of PbBfor example, lifetime peak PbB, time weighted PbB-and zinc protoporphyrin concentrations-for example, lifetime peak zinc protoporphyrin, time weighted zinc protoporphyrin-but not with measures of estimated external exposure-for example, duration of exposure and cumulative exposure to inorganic or organic lead. Among workers with higher chelatable lead burdens (6 h PbU 212-4 ug (103 ,umol) divided at the median), there was no apparent relation between recent inorganic lead exposure and PbB at the time of chelation. Among workers with lower chelatable lead burdens (6 h PbU < 212*4 ug (1.03 umol) however, there was a significant relation between exposure and effect between recent exposure to inorganic lead and PbBs. Conclusion-These findings are consistent with the concept of physiological dampening. The high chelatable lead burden, a source of internal exposure, dampens the effect of external exposure on PbBs. The data suggest that in organolead workers with high chelatable lead burdens, PbBs may be more influenced by internal lead stores than by variations in airborne exposure to organic and inorganic lead. The organolead compounds most commonly encountered in the workplace are tetraethyl and tetramethyl lead, both components of additives for gasoline and aviation fuel. Use in the United States has greatly diminished since the introduction of catalytic converters into vehicles in 1975, but worldwide production and use is still considerable and represents an important occupational and environmental hazard. ' After absorption, tetraethyl lead is rapidly dealkylated primarily in the liver by cytochrome P-450 mixed function oxidases to the toxic metabolite triethyl lead,2-4 or possibly directly to inorganic lead.5 6 Triethyl lead has been found to be relatively persistent in rodent tissues, with estimated half lives of 15 days in the liver and kidney, 7 days in the brain, and 3-5 days in blood.6 It is further metabolised to diethyl lead, an important urinary excretion product, then to inorganic lead, which can be excreted in the urine or stool, or stored in bone as the main portion of the body's burden of lead.4 Precipitable lead (inorganic lead) is produced rapidly, but it disappears rapidly from tissues, probably due to uptake by bones.5 Studies in humans suggest that such bone lead represents 95% of the body's burden of lead,7 with an estimated half life of elimination of 5-20 years. 8 Although ethylene diamine tetraacetic acid (EDTA) does not chelate organolead compounds in vitro or in vivo,39 enhancement of urinary lead excretion (PbU) after EDTA treatment of patients with acute organolead poisoning has been documented in several case reports.9 Arai reported that in a worker with tetraethyl lead poisoning 22 days after exposure, PbU output was 51 % inorganic, 43% diethyl lead, and 6% triethyl lead.9 Administration of EDTA resulted in increased urinary excretion of inorganic lead but not organic lead.
No previous studies have compared measures of exposure, dose, and chelatable lead burden in workers exposed to organolead. Although several case series have been reported concerning chelation in inorganic lead workers, exposure measures from epidemiological exposure assessment have not been used. In this study, the primary interest was to identify the determinants of blood lead concentrations (PbBs) in subjects exposed to lead. Specifically, we were interested in the extent to which internal lead stores and ongoing external exposure govern PbBs. A secondary aim was to describe lead excretion after administration of EDTA in organolead workers and determine the predictors of lead excretion in such workers.
Materials and methods

STUDY POPULATION
This case series consists of 21 Provocative chelation was performed with 1 g of EDTA given intravenously in 500 ml normal saline over 1 h, followed by a 6 h urine collection. For all workers, 24 h lead excretion was estimated from the 6 h urinary lead excretion (6 h PbU) value by the following equation: 24 h lead (upg) = 113-2 + 2-31 x 6 h PbU (ag). 15 
MEASURES OF EXPOSURE AND DOSE
Several measures of work related external exposure to organic and inorganic lead and of internal dose were derived.'4 Histories of individuals' exposure were derived after linkage of personal industrial hygiene data with daily hours worked, obtained by interview, in 29 exposure zones in the lead area of the plant, for all jobs ever held in the lead area. The personal industrial hygiene data, available from the previous 12 years but with half the samples from 1989-90, were grouped by exposure zone and the arithmetic mean was used as the summary measure of the intensity of exposure in the zone. The assigned exposure intensities in the 29 zones ranged from 4-119 jug/ml (0-02-0-57 jimol/m' as lead) for organic lead and 1-56 p1g/M3 (0004-0-27 pImollm3) for inorganic lead. '4 The exposure histories consisted of mixed exposure to inorganic and organic lead, and were estimated for 100 day employment intervals in jpg days/M3. The histories were used to create three main measures of external exposure: cumulative exposure to organic and inorganic lead during employment at the plant; recent (past 30 days) exposure to organic and inorganic lead; and lifetime weighted average intensity of exposure to organic and inorganic lead, dividing cumulative exposure by duration of exposure. Duration of exposure was also derived from the histories of exposure and was the final exposure variable to be assessed. Questionnaire data showed that no workers had occupational exposure to lead before employment in the plant or significant current or past non-occupational exposure to lead.
The PbBs, PbUs, and zinc protoporphyrin (ZPP) concentrations were monitored by the employer and were abstracted from plant medical records. These were used to derive three measures each for PbU, PbB, RECINO is different for subjects with high and low chelatable lead burdens, as estimated by 6hPbU). Other footnotes as for table 3. height, weight, cigarette smoking, renal function, and job title were not associated with 6 h PbU.
PREDICTORS OF BLOOD LEAD AT THE TIME OF CHELATION
In bivariate analyses, PbBc was positively correlated with recent organic and inorganic lead exposure (table 2); and lifetime weighted average intensity of exposure to total (r = 0-48, P = 0 03) and inorganic (r = 0-64, P = 0-003) lead. The PbBc was negatively correlated with age and exposure duration. In multiple linear regression analyses, recent inorganic lead exposure and chelatable lead burden (6 h PbU) were both independent predictors of PbBc (table 4) . An 
